Kristin King

Advisor at Xylyx Bio

Dr. Aranda is a cancer biologist with more than 10 years of experience studying the mechanisms involved in tumor development. Her research was focused on investigating the role of macrophages in tumoral angiogenesis using mouse models of breast cancer. Furthermore, she studied the role of new anti-angiogenic drugs using pancreatic cancer models. Evelyn also has experience in teaching different Biology courses to undergraduate students.

She received her Ph.D. from the Physiology Department at the Pontificia Universidad Católica de Chile and did her postdoctoral training at the Developmental and Biology Department of Albert Einstein College of Medicine.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Xylyx Bio

1 followers

Xylyx Bio's platform technology of tissue-specific ECM substrates, clinically relevant data packages, and compound testing services increases predictiveness and informs better decision making in drug discovery, saving precious time and money in the quest to develop lifesaving drugs.


Industries

Employees

11-50

Links